These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4026251)

  • 1. [Pharmacokinetics of the new antitumor antibiotic reumycin in an experiment: the prediction of the human pharmacokinetic profiles].
    Firsov AA; Geodakian SV; Terent'eva TG; Fomina IP
    Antibiot Med Biotekhnol; 1985 Apr; 30(4):296-301. PubMed ID: 4026251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical pharmacokinetics of the antitumor antibiotic reumycin: an analysis of individual variability].
    Firsov AA; Geodakian SV; Lichinitser MR; Shutka VIa
    Antibiot Med Biotekhnol; 1985 Aug; 30(8):604-8. PubMed ID: 4062279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetic study of aclarubicin. The pharmacokinetics of the preparation and its biologically active metabolites in the blood of rats].
    Geodakian SV; Firsov AA; Fomina IP
    Antibiot Med Biotekhnol; 1987 Oct; 32(10):768-72. PubMed ID: 3480699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of alkaline hydrolysis of reumycin using NMR spectroscopy].
    Shorshneva SV; Esipov SE; Chernyshev AI
    Antibiot Med Biotekhnol; 1987 Feb; 32(2):116-20. PubMed ID: 3566231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Structure and physicochemical properties of isolated molecules of reumycin].
    Sheina GG; Esipov SE; Ivanov AIu; Stepan'ian SG
    Antibiot Med Biotekhnol; 1987 Feb; 32(2):111-5. PubMed ID: 3566230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of the action of the antitumor antibiotic reumycin on the macroorganism].
    Egorenko GG; Shtegel'man LA; Solov'ev VN; Berezina EK; Berezhinskaia VV
    Antibiotiki; 1976 Feb; 21(2):178-82. PubMed ID: 1275471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Action of reumycin on the blood system in an experiment].
    Svinogeeva TP; Berezina EK; Raĭko LI
    Antibiotiki; 1984 Jul; 29(7):516-9. PubMed ID: 6486750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modelling of rifampicin pharmacokinetics in experimental animals administered the drug intravenously and internally].
    Firsov AA; Umnova LV; Stepanov VM; Fomina IP
    Antibiot Med Biotekhnol; 1986 Jun; 31(6):445-9. PubMed ID: 3740826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The antiblastic properties of reumycin (experimental research)].
    Romodanov SA; Semenova VM; Oleĭnik GM
    Zh Vopr Neirokhir Im N N Burdenko; 1991; (2):13-6. PubMed ID: 1656661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Free radical mechanism of action of pyrimido-triazine antibiotics].
    Orlov VS; Bogdanov GN; Emanuél' NM; Esipov SE; Navashin SM
    Bioorg Khim; 1983 Apr; 9(4):556-60. PubMed ID: 6091693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1.
    Egorin MJ; Zuhowski EG; Rosen DM; Sentz DL; Covey JM; Eiseman JL
    Cancer Chemother Pharmacol; 2001 Apr; 47(4):291-302. PubMed ID: 11345645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary pharmacokinetics of a new pyridopyrimidine derivative.
    Pérez MJ; Roch MJ; Ochoa MC
    Arzneimittelforschung; 1991 Jun; 41(6):640-4. PubMed ID: 1930354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and tissue distribution of rifametane, a new 3-azinomethyl-rifamycin derivative, in several animal species.
    Bruzzese T; Rimaroli C; Bonabello A; Mozzi G; Ajay S; Cooverj ND
    Arzneimittelforschung; 2000 Jan; 50(1):60-71. PubMed ID: 10683718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetic study of aclarubicin. The distribution of the preparation and its biologically active metabolites in rat tissues].
    Firsov AA; Geodakian SV; Egorov LV; Terent'eva TG
    Antibiot Med Biotekhnol; 1987 Oct; 32(10):773-7. PubMed ID: 3480700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cephalexin pharmacokinetics].
    Koroleva VG; Vasil'ev VK; Danilova VI; Firsov AA
    Antibiotiki; 1981 Mar; 26(3):113-6. PubMed ID: 7235651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of the antitumor antibiotic bleomycetin in cancer patients given the preparation by different methods].
    Smolianskaia AZ; Spitsyna TA; Manziuk LV
    Antibiotiki; 1984 Aug; 29(8):616-9. PubMed ID: 6207770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, protein binding, pharmacokinetics and excretion of the anti-ischemic and anti-hypertensive arylpiperazine derivative CDRI-93/478 in rats.
    Lal J; Gupta RC
    Arzneimittelforschung; 2008; 58(2):62-70. PubMed ID: 18412019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and metabolism of gabapentin in rat, dog and man.
    Vollmer KO; von Hodenberg A; Kölle EU
    Arzneimittelforschung; 1986 May; 36(5):830-9. PubMed ID: 3730018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Action of antibiotic 1719 from a group of diazo compounds on hematopoiesis in laboratory animals and its pharmacokinetics].
    Vertogradova TP; Kunrat IA
    Antibiotiki; 1975 Jan; 20(1):26-31. PubMed ID: 1122124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.